Investment Team Project

In the beginning of the stock market game I bought only stocks in only 5 different companies, those companies were all companies that I was familiar with. The five companies were Apple, American Eagle, Costco, Disney and Hershey. I bought Apple stock because who doesn’t think of Apple when they think of big companies with a lot of money.

CVS Caremark is a pharmaceutical company that is considered one of the largest suppliers of both over-the-counter and prescription medicine in the world. They’ve been named best in their industry over the past few years by Forbes magazine and continue to own one of the highest revenue marks in the country in the healthcare industry. On top of all these accolades that they have been receiving in recent years, the company is still growing at an exponential rate. On New Year’s Day in 2011, the closing stock price for CVS was $33.31. As of April 19th, 2015, the closing price according to the NYSE was at an astounding $100.39. That is over a 200% growth in

The company is so large that no one drug can lift it from its current sales doldrums. In addition, the company was once highly attractive to investors, but its recent stock price fell to 1997 lows. This may put pressure on the company to attempt acquisitions at a time when the company is ill-equipped to integrate a new company into its organization, and it is engaged in a cost-cutting program at a time when it may need to invest even more in research and development (McTigue Pierce, 2005).

The two firms that I have chosen for this Investment Recommendation Report are Bon- Ton Stores, Inc. and Dick’s Sporting Goods. Bon- Ton and Dick’s both share some similarities in the merchandise that they sell in terms of clothing and apparel but they are categorized in two different industries. Dick’s is a member of the sporting goods industry while Bon Ton is part of the retail industry.

From the beginning of the live marketing project, Edmond's Historical Museum, to the end of the live presentation, I committed 100% of myself to the team by being actively involved. My first contribution was visiting the Edmond's Historical Museum on September 28th, 2017 where I gathered notes by effectively listening to Katie Kelly. This was for the purpose of being able to analyze the data at a later time. The data research that I was able to gleam from Katie, included that the museum is seeing a decline in their memberships, there was not enough volunteers to actively seek out renewals, and a majority of the Edmond's transplants moved changing the demographics, and that new exhibits would come

Although, not surprised by the CVS impressive financial portfolio when compared to other similar firms within the health industry, the extent of the corporation’s financial bliss is pleasantly amazing. The corporation is currently in competition with financially healthy companies such as WalMart, Walgreens and target to name a few; and the market cap for CVS is 117.01Bilion dollars compared to the industry’s average of 3.45 Billion dollars. Unfortunately, the CVS market cap is second

This initiative creates an impression of an environmentally friendly company hence creating a greater appeal for the company’s products. Colgate-Palmolive created 275 new products and introduced them to global markets in the last five years. The company then ensured product presence by building factories in China and Europe.

I started out by reading yahoo financial to find any info that would help me out to find out if it would be a good investment at this time. The first thing that stood out was that it had a beta of 1.44362 as of the time this was written. That tells me that this is a stable stock almost near the Market. With a Market capital 585.95 billion shows that they have built a strong stock that most investors would easily consider. They have shown that prior to 2001 they have really made a stable comeback. They really have shown strong earnings to go with lots of institutional investing. They

Further, our strategy involved paying attention to current events and attempting to use them to generate a return. For example, Horizon Pharmaceuticals’ stock price took a nosedive after an October 19th New York Times article suggested that Horizon was attempting to thwart Express Scripts’ attempts to lower the price of prescription drugs. The decision was made to buy 100 shares of stock in Horizon when its price spiraled down to a measly $14.62 per share, as we expected Horizon would do something to stop the bleeding, and historically has been a pretty volatile stock. Horizon came back with a scorching rebuttal in an open letter later that day, spiking its stock price more than 30% on October 23rd, and by October 28th, this move landed us our greatest return of any stock that we purchased and held until the end of the period: 18% (see appendix).

Many analysts would note that based on the consensus of the world population, the company’s equity is of the highest value as they are currently ranked as industry leader in market capitalization (source: Yahoo Finance) which conveniently brings me to my next evaluation.

My first choice was AbbVie Inc., or (ABBV), and on the date of purchase their stock was trading at $64.08 per share. On the date of purchasing their stock I bought 312 shares equaling a total of $19,992.96. This company is known for discovering, developing, and marketing both biopharmaceuticals and small molecule drugs. One drug that is known as the world 's best selling anti-inflammatory medicine is Humira, which was made by AbbVie. Drugs like Humira and Vicodin have proved to be household names. I chose AbbVie incorporated because their drugs are some of the best on the market and cater to the needs of the masses.

The leading market position along with the well-diversified product portfolio enables the company to gain excess profits. At first glance, the company is in a healthy financial

I have picked Glencore Plc because looking at the crisis Glencore have been facing for the past period of time, in my opinion as very important and showed to me the amount of risk them were facing on their behalf.

Our back up strategy is to invest in companies that are well established and they have promising potential for growth and expansion. Companies that fall under this category of expected growth are Tiger Brands, Discovery, Pick ‘n Pay. There was an upward trend path in the growth of these shares and their respective values.

Annual rate of return of each company seems to be high, which can meet the requirement of a risk-averse investor.